AU516033B2 - Substituted 2, 3-alkylene bis (oxy) benzamide derivatives - Google Patents

Substituted 2, 3-alkylene bis (oxy) benzamide derivatives

Info

Publication number
AU516033B2
AU516033B2 AU27507/77A AU2750777A AU516033B2 AU 516033 B2 AU516033 B2 AU 516033B2 AU 27507/77 A AU27507/77 A AU 27507/77A AU 2750777 A AU2750777 A AU 2750777A AU 516033 B2 AU516033 B2 AU 516033B2
Authority
AU
Australia
Prior art keywords
oxy
substituted
benzamide derivatives
alkylene bis
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU27507/77A
Other languages
English (en)
Other versions
AU2750777A (en
Inventor
M. ET AL Thommen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Original Assignee
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/fr
Application filed by Societe dEtudes Scientifiques et Industrielles de lIle de France SA filed Critical Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Publication of AU2750777A publication Critical patent/AU2750777A/en
Application granted granted Critical
Publication of AU516033B2 publication Critical patent/AU516033B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU27507/77A 1976-08-04 1977-08-01 Substituted 2, 3-alkylene bis (oxy) benzamide derivatives Expired AU516033B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FRFR76-23835 1976-08-04
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU62815/80A Division AU529379B2 (en) 1976-08-04 1980-09-30 Substituted - 2,3 - alkylene bis (oxy) benzole acis

Publications (2)

Publication Number Publication Date
AU2750777A AU2750777A (en) 1979-02-08
AU516033B2 true AU516033B2 (en) 1981-05-14

Family

ID=9176558

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27507/77A Expired AU516033B2 (en) 1976-08-04 1977-08-01 Substituted 2, 3-alkylene bis (oxy) benzamide derivatives

Country Status (37)

Country Link
JP (1) JPS57167914A (da)
AR (1) AR219709A1 (da)
AT (1) AT358034B (da)
AU (1) AU516033B2 (da)
BE (1) BE857350A (da)
BG (1) BG36496A3 (da)
CA (1) CA1114371A (da)
CH (1) CH629198A5 (da)
CS (1) CS216246B2 (da)
DD (1) DD133237A5 (da)
DE (1) DE2760414C2 (da)
DK (1) DK152366C (da)
EG (1) EG12716A (da)
ES (1) ES461175A1 (da)
FI (1) FI63938C (da)
GR (1) GR61351B (da)
HK (2) HK40382A (da)
HU (1) HU179064B (da)
IE (2) IE45646B1 (da)
IL (2) IL52644A0 (da)
IN (1) IN145473B (da)
LU (1) LU77897A1 (da)
MC (1) MC1154A1 (da)
MW (1) MW2077A1 (da)
NL (1) NL172063C (da)
NO (1) NO152133C (da)
NZ (1) NZ184816A (da)
OA (1) OA05728A (da)
PH (3) PH22114A (da)
PL (1) PL111071B1 (da)
PT (1) PT66865B (da)
RO (1) RO72963A (da)
SE (2) SE440776B (da)
SU (1) SU716523A3 (da)
YU (1) YU40005B (da)
ZA (1) ZA774701B (da)
ZM (1) ZM6077A1 (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651645B2 (en) * 1990-12-13 1994-07-28 Beecham Group Plc Pharmaceuticals

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device
JP6452575B2 (ja) * 2015-08-19 2019-01-16 株式会社トクヤマ ミルタザピンの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (fr) * 1964-06-09 1967-03-24 Ile De France Nu-(tertiaire-aminoalkyl)-méthylène dioxybenzamides et leur préparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651645B2 (en) * 1990-12-13 1994-07-28 Beecham Group Plc Pharmaceuticals

Also Published As

Publication number Publication date
PT66865B (fr) 1978-12-29
IN145473B (da) 1978-10-21
PT66865A (fr) 1977-08-01
EG12716A (en) 1979-09-30
CA1114371A (en) 1981-12-15
HU179064B (en) 1982-08-28
FI772362A (da) 1978-02-05
IE45647B1 (en) 1982-10-20
ZA774701B (en) 1979-01-31
NL7708616A (nl) 1978-02-07
PL200066A1 (pl) 1978-09-11
DK152366B (da) 1988-02-22
PH17710A (en) 1984-11-19
ZM6077A1 (en) 1979-05-21
AU2750777A (en) 1979-02-08
ES461175A1 (es) 1978-12-01
DD133237A5 (de) 1978-12-20
SE8206546D0 (sv) 1982-11-17
OA05728A (fr) 1981-05-31
AR219709A1 (es) 1980-09-15
DE2760414C2 (da) 1990-05-17
HK40482A (en) 1982-09-24
MC1154A1 (fr) 1978-04-17
BE857350A (fr) 1978-02-01
PL111071B1 (en) 1980-08-30
JPS57167914A (en) 1982-10-16
DK152366C (da) 1988-07-25
CS216246B2 (en) 1982-10-29
SE437027B (sv) 1985-02-04
IE45646L (en) 1978-02-04
BG36496A3 (en) 1984-11-15
RO72963A (ro) 1981-11-24
LU77897A1 (da) 1978-02-09
NO152133B (no) 1985-04-29
GR61351B (en) 1978-10-26
FI63938B (fi) 1983-05-31
SE7708849L (sv) 1978-02-05
NL172063B (nl) 1983-02-01
SE8206546L (sv) 1982-11-17
SU716523A3 (ru) 1980-02-15
YU188277A (en) 1983-01-21
PH18629A (en) 1985-08-23
IL66138A0 (en) 1982-09-30
FI63938C (fi) 1983-09-12
ATA569677A (de) 1980-01-15
IE802409L (en) 1978-02-04
HK40382A (en) 1982-09-24
NO152133C (no) 1985-08-07
PH22114A (en) 1988-06-01
SE453390B (sv) 1988-02-01
DK346977A (da) 1978-02-05
NL172063C (nl) 1983-07-01
IL52644A0 (en) 1977-10-31
SE440776B (sv) 1985-08-19
CH629198A5 (fr) 1982-04-15
IE45646B1 (en) 1982-10-20
JPS6259090B2 (da) 1987-12-09
MW2077A1 (en) 1978-12-13
NO772739L (no) 1978-02-07
NZ184816A (en) 1980-11-14
YU40005B (en) 1985-06-30
AT358034B (de) 1980-08-11

Similar Documents

Publication Publication Date Title
AU513281B2 (en) 3,7-disubstituted -3- cephem -4-carboxylic acid compounds
AU503557B2 (en) N, n' alkylene-bis-tetrabromo-phthalimides
AU517020B2 (en) 10, 19-dihydro-vitamin d compounds
AU508007B2 (en) 1, 5-Disubstituted-2-Pyrrolidones
AU512404B2 (en) 2, 6-Methano-2H-l-Benzoxocins
AU508891B2 (en) 5,6-dihydro-prostacyclin analogs
AU513812B2 (en) Substituted 2, 1, 3-benzothiadiazine compounds
AU515495B2 (en) 5, 5-trimethylhexanoyl-ferrocene
AU500386B2 (en) 1,2,6-thidiazinones
AU506573B2 (en) 3'phenoxybenzyl-l-phenyl-cyclobutane-l-carboxylate derivatives
AU516033B2 (en) Substituted 2, 3-alkylene bis (oxy) benzamide derivatives
AU512931B2 (en) 13, 14-didehydro prostaglandin
AU517895B2 (en) 1, 3-dihydro-1-dimethyl phosphinylalkyl 3 phenylspiro ( iosbenzofurn)s
AU506714B2 (en) Bis benzopyram derivatives
AU510764B2 (en) Preparation of 2, 3-Dichloroanisole
SU646064A1 (ru) Кривошипно-ползунный механизм
AU514741B2 (en) 5,6-dehydropenicillins
AU524600B2 (en) 2,6-methano-3-benzazocines
AU518146B2 (en) Substituted bis (amidinoureas)
AU496552B2 (en) Prostaglandin-type 1, 11-lactones
AU514806B2 (en) 1, 3, 5-triazapenta-1, 4-diene-phosphorus derivatives
AU515307B2 (en) 1, 3-benzodioxine derivatives
AU520088B2 (en) 1, 2, 3, 4-tetrahydro-naphthalenes
AU529379B2 (en) Substituted - 2,3 - alkylene bis (oxy) benzole acis
AU496088B2 (en) Prostaglandin-type 1, 9-lactones